It's Time To Focus On The Long Run With Ambrx Biopharma Inc. (AMAM) stock

Retrieved on: 2022-12-28 00:25:24

Tags for this article:

Click the tags to see associated articles and topics

It's Time To Focus On The Long Run With Ambrx Biopharma Inc. (AMAM) stock. View article details on hiswai:

Excerpt

Ambrx Biopharma Inc. (NYSE: AMAM) closed the day trading at $1.62 down -1.22% from the previous closing price of $1.64. In other words, the price ...

Article found on: dwinnex.com